AstraZeneca Aktie
127,25
EUR
+0,90
EUR
+0,71
%
110,74
GBP
+0,74
GBP
+0,67
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Deutsche Bank AG | 110,00 GBP | - | 18.09.2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 142,00 GBP | - | 17.09.2025 | |
| JP Morgan Chase & Co. | 140,00 GBP | - | 17.09.2025 | |
| UBS AG | 142,00 GBP | - | 05.08.2025 | |
| Bernstein Research | 180,00 GBP | - | 04.08.2025 | |
| Jefferies & Company Inc. | 109,00 GBP | - | 29.07.2025 | |
| Goldman Sachs Group Inc. | 148,06 GBP | - | 03.07.2025 | |
| DZ BANK | - | - | 30.04.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 3 | 0 | 138,72 GBP | - |
| Bayer | 2 | 7 | 0 | 26,88 EUR | -1,77% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +37,98% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 2 | 0 | 8,42 EUR | +41,89% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 6 | 2 | 0 | 148,71 EUR | +39,77% |
| Moderna Inc | 0 | 1 | 0 | 42,00 USD | +71,50% |
| Novartis AG | 3 | 4 | 2 | 98,25 CHF | -0,08% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,33 USD | +23,44% |
| Roche AG (Genussschein) | 3 | 2 | 3 | 280,90 CHF | +10,98% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 8 | 1 | 0 | 110,75 EUR | +41,90% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |